JPH027631B2 - - Google Patents

Info

Publication number
JPH027631B2
JPH027631B2 JP8371088A JP8371088A JPH027631B2 JP H027631 B2 JPH027631 B2 JP H027631B2 JP 8371088 A JP8371088 A JP 8371088A JP 8371088 A JP8371088 A JP 8371088A JP H027631 B2 JPH027631 B2 JP H027631B2
Authority
JP
Japan
Prior art keywords
culture
ethanol
precipitate
solution
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP8371088A
Other languages
Japanese (ja)
Other versions
JPS63273471A (en
Inventor
Kyoshi Sato
Kazukyo Inoe
Hiroshi Korenaga
Shunichiro Ooga
Toshihiko Kumada
Shizuo Kadoya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Priority to JP8371088A priority Critical patent/JPS63273471A/en
Publication of JPS63273471A publication Critical patent/JPS63273471A/en
Publication of JPH027631B2 publication Critical patent/JPH027631B2/ja
Granted legal-status Critical Current

Links

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明はAT−25菌に関するものである。 本発明者は、微生物生産物の中に抗血栓作用を
有するものを探索した結果、分離番号AT−25で
ある菌の培養濾液及びその菌体抽出液が優れた抗
血栓作用を示すことを見出した。その後研究を重
ねた結果、本発明者は、その活性本体を分離精製
することに成功し、硫酸化多糖体を主構成成分と
する新規物質であることを確認した。従来硫酸化
多糖体としては動物由来のヘパリンがよく知られ
ているが、微生物によつて直接に硫酸化多糖体が
産生される事実は極めて稀であり、本発明者の文
献調査では次の報告が見られるのみである。すな
わち、ダービイ(Darby)らのClostridium
welchiiの夾膜成分としてデルマタン硫酸様高分
子の存在に関する報告(J.Bacteriology、103
159(1970))またはステバー(Steber)らの
Halococcus morrhuae菌の細胞壁成分としてグ
ルコース、マンノース、ガラクトースから成る硫
酸化多糖体の報告(Archives of Microbiology
105、173(1975))の二例に限られる。しかし、
これら既報の生産菌および産生物質は、本発明に
系わるAT−25菌およびDF−4639とは、後述の
如く明らかに異なるものである。硫酸化多糖体
DF−4639を生産するにはDF−4639生産菌を培養
すればよいが、最も代表的な方法は、AT−25菌
またはその変異株をその菌が成育し得る培地中で
培養し、培養液または菌体から分離精製すること
である。 AT−25菌は、本発明者が土壌試料から新たに
分離した菌であり、分類学的に検討した結果新菌
種であると推定し、暫定的にミクロコツカス属
(Micrococcus sp.)AT−25と名付け、微工研菌
寄第5255号として、またアルスロバクター属
(Arthrobacter sp.)AT−25として微工研条菌
寄第1357号として微生物工業技術研究所に寄託保
存されている。以下本菌をAT−25菌と略記する
ことがある。 AT−25菌の菌学的性質は次の通りである。 (a) 形態 球状乃至短桿状(培養後期に球状)、径0.5
〜0.7×0.7〜1.5μm、多形性あり、運動性
なし、胞子形成なし、グラム染色陽性、
抗酸性なし (b) 各培地における成育状態 肉汁寒天平板培養 点状または円形状に中程度の発育で、光沢
ある山吹茶色を示すが、拡散性はなし。 肉汁寒天斜面培養 糸状に成育する他は、の平板培養の場合
と同様であつた。 肉汁寒天液体培養 菌膜形成はなく、全体に濁りおよび沈査あ
り。 肉汁ゼラチン穿刺培養(22℃培養) 穿刺線に沿つて成育し、かぶ状に液化す
る。 リトマスミルク培地 リトマスをやや赤変する。また長期培養
(14日以上)では凝固も見られる。 (c) 生理学的諸性質 硝酸塩の還元 陰性、脱窒反応 陰性、
MR反応 陰性、VP反応 陰性、イン
ドールの生成 なし、硫化水素の生成 な
し、デンプンの加水分解能 なし、クエン
酸の利用能 なし、無機窒素源の利用能 あ
り、水不溶性の色素生成 あり、ウレアー
ゼ作用 なし、オキシターゼ作用 なし、
カタラーゼ作用 あり、生育の範囲 PH6.0
〜8.5(最適7〜8)、温度10〜37℃(最適27〜
30℃)、好気性、OF反応 陰性、下記15
種の糖類からの酸およびガスの生成はなし。 L−アラビノース D−ガラクトース D−キシロース 表芽糖 D−グルコース シヨ糖 D−マンノース 乳 糖 D−フラクトース トレハロース D−ソルビツト D−マンニツト グリセリン イノシツト デンプン (d) その他の諸性質 フオスフアターゼ作用 なし、 アルギニンの分解能 なし、 塩化ナトリウム7.5%中では成育するが10
%中では成育せず、 ノボビオシンおよびリゾチームに対する最
小発育阻止濃度は共に3.1μg/ml、 グアニンおよびシトシン含量(GC含量)
72.9%、 菌体内色素(黄色)産生、 細胞壁成分にジアミノピメリン酸(DAP)
あり。 以上の菌学的性質を、バージイのマニユアル
(Bergey′s Manual of Determinative
Bacteriology、8th Ed.R.E.Buchaman and N.
E.Gibbons(Williams and Wilkins Co.、1974))
の記載に照すと、本菌はグラム陽性の短桿菌で運
動性がなく、カタラーゼ陽性、オキシターゼ陰
性、抗酸性がなく胞子形成が見られない、耐塩性
はあるが、食塩10%以上含有すれば成育しえな
い、絶対好気性であり、OF試験においても非醗
酵的である。VP反応、アルギニン分解能および
フオスフアターゼ活性は陰性であるなどの諸性質
から、アルスロバクター属に属せしめるのが最も
妥当である。 次に硫酸化多糖体DF−4639を得るための基本
的な方法についてのべる。すなわち、DF−4639
を取得するために用いた菌の培養液および菌体内
にDF−4639が蓄積すればよいわけで、それには
用いた菌が成育しうる培地であればすべて使用可
能であり、用いた菌が資化しうる炭素源、窒素源
の他に無機塩やビタミン類を単独に、あるいは適
当な割合に組合せて用いることができる。炭素源
としてはブドウ糖、グリセリンなど、窒素源とし
ては酵母エキス、肉エキス、ペプトン、大豆粉、
コーンステイープリカーや燐酸水素アンモニウ
ム、硝酸アンモニウムなどの無機アンモニウム塩
が用いられ、そのほかに無機塩としてマグネシウ
ム、カリウム、鉄、マンガンなどの金属塩の適当
量の添加が可能である。また、DF−4639は硫酸
化多糖体であるので、硫酸ナトリウムや硫酸アン
モニウムの如き硫酸塩類を適当量加えることは極
めて有意義である。培養温度や培地のPHは使用し
た菌が成育しうる範囲であればよいが、温度は25
〜37℃、PHは6.5〜8.5の間で培養するのが好まし
い。培養は好気的条件で行うのがよく、例えば振
盪培養法もしくは培養槽内で通気撹拌培養を行な
えばよい。培養時間は24時間以上であればよい
が、50〜200時間が好ましい。 培養が終了すれば、培養物を遠心分離機にかけ
て菌体と濾液とに分け、濾液については大略以下
に述べる如く処理する。なお、菌体については、
その量が少ない場合は無視し得るが、多量の場合
は後述する方法に従い別に処理する。 すなわち、濾液に第4級アンモニウム塩、例え
ばセチルピリジニウムクロライド(CPC)の溶
液を加えて撹拌し、生じる沈澱を高速遠心機にか
けて分離して集める。得られた沈澱に適当な濃度
の電解質溶液、例えば10%エタノール含有の3モ
ル食塩水を加えて撹拌溶解せしめる。エタノール
を新たな沈澱が生じなくなる迄加え、生じた沈澱
を集め、エタノールそしてアセトンで洗つた後乾
燥すれば、粗粉末が得られる。ここに得られた粗
粉末を再び水に溶解し、稀塩酸を加えてPHを約
1.0とした後低温(約5℃)で遠心分離して不溶
物を除去する。上清を集め、希苛性ソーダ液で中
和しこれに第4級アンモニウム塩、例えばセチル
トリメチルアンモニウムブロマイド(CTAB)
水溶液を加えて生じる沈澱を遠心分離して集め
る。得られた沈澱を1モル食塩水中に加えて核酸
などの夾雑物を充分に撹拌可溶化した後、遠心分
離して不溶分を集める。この不溶物を10%エタノ
ール含有の3モル食塩水に加えて約50℃に加温し
つつ溶解する。この溶解にエタノールを加えて沈
澱させ、生じた沈澱を集めてエタノール、ついで
アセトンで洗つた後、再び水に室温で撹拌しなが
ら溶解させ約5℃で遠心分離して微量の不溶物を
除去する。溶液に新たな沈澱が生じなくなる迄エ
タノールを加え、生じた沈澱を集め、順次エタノ
ール、アセトンおよびエーテルで洗つた後、約70
℃で減圧乾燥すればDF−4639が白色粉末として
得られる。 一方、菌体からDF−4639を得るには菌体の水
懸濁液にトルエンなどを加えて室温に放置して菌
体を自己融解させ、菌体内成分を水に移行させ
る。この懸濁液にエタノールを40%になる迄加
え、沈澱する蛋白、核酸などを菌体残渣と共に濾
過して除き、濾液を濃縮してエタノールを留去す
る。これにCPC溶液を加えて生じる沈澱を集め、
以下培養濾液の場合と同様に処理する。 上述の方法によればDF−4639は、硫酸化多糖
体のナトリウム塩として得られ、以下の物理化学
的諸性質を有する。 (a) 元素分析値、糖および蛋白含量 5ロツトの値および平均値を第1表に示し
た。
The present invention relates to AT-25 bacteria. As a result of searching for microbial products that have antithrombotic effects, the present inventor found that the culture filtrate of the bacteria with isolation number AT-25 and its bacterial cell extract exhibited excellent antithrombotic effects. Ta. As a result of subsequent research, the present inventor succeeded in separating and purifying its active substance, and confirmed that it is a new substance whose main component is a sulfated polysaccharide. Conventionally, animal-derived heparin is well known as a sulfated polysaccharide, but the fact that sulfated polysaccharides are directly produced by microorganisms is extremely rare, and the inventor's literature research revealed the following report. can only be seen. Namely, Clostridium of Darby et al.
Report on the existence of dermatan sulfate-like polymer as a capsular component of M. welchii (J.Bacteriology, 103 ,
159 (1970)) or Steber et al.
A report on sulfated polysaccharides consisting of glucose, mannose, and galactose as cell wall components of Halococcus morrhuae (Archives of Microbiology)
105 , 173 (1975)). but,
These previously reported producing bacteria and produced substances are clearly different from the AT-25 bacteria and DF-4639 related to the present invention, as described below. sulfated polysaccharide
DF-4639 can be produced by culturing DF-4639-producing bacteria, but the most typical method is to culture AT-25 bacteria or its mutants in a medium in which the bacteria can grow, and then add the culture solution. Alternatively, it can be separated and purified from bacterial cells. The AT-25 bacterium is a bacterium newly isolated by the present inventor from a soil sample, and as a result of taxonomic examination, it is estimated that it is a new bacterial species, and tentatively it belongs to the genus Micrococcus (Micrococcus sp. AT-25). It has been deposited and preserved at the National Institute of Microbial Technology as Microbiological Research Institute No. 5255, and as Arthrobacter sp. AT-25, Microbiological Research Institute No. 1357. Hereinafter, this bacterium may be abbreviated as AT-25 bacterium. The mycological properties of AT-25 bacteria are as follows. (a) Morphology: spherical to short rod-like (spherical at late stage of culture), diameter 0.5
~0.7 x 0.7-1.5 μm, pleomorphic, non-motile, no sporulation, positive Gram staining,
No acid-fastness (b) Growth status in each medium Broth agar plate culture Moderate growth in dotted or circular shapes, with a shiny golden brown color, but no diffusivity. Juicy agar slant culture The growth was similar to that of the plate culture except that it grew in a filamentous manner. Meat juice agar liquid culture No bacterial film formation, turbidity and sediment throughout. Meat juice gelatin puncture culture (culture at 22°C) Grows along the puncture line and liquefies into a turnip. Litmus milk medium Turns litmus a little red. Coagulation is also observed in long-term culture (14 days or more). (c) Physiological properties Nitrate reduction negative, denitrification reaction negative,
MR reaction negative, VP reaction negative, indole formation none, hydrogen sulfide generation none, starch hydrolysis ability none, citric acid utilization none, inorganic nitrogen source utilization yes, water-insoluble pigment formation yes, urease action none , no oxidase action,
Catalase action, growth range PH6.0
~8.5 (optimum 7~8), temperature 10~37℃ (optimum 27~
30℃), aerobic, OF reaction negative, below 15
No acid and gas production from seed sugars. L-arabinose D-galactose D-xylose Epidermis D-glucose Sucrose D-mannose Lactose D-fructose Trehalose D-sorbitol D-mannite Glycerin Inosit Starch (d) Other properties Phosphatase action None, ability to decompose arginine None , grows in 7.5% sodium chloride, but 10
%, the minimum inhibitory concentrations for novobiocin and lysozyme are both 3.1 μg/ml, and the guanine and cytosine content (GC content)
72.9%, intracellular pigment (yellow) production, diaminopimelic acid (DAP) as a cell wall component
can be. The above mycological properties are described in Bergey's Manual of Determinative.
Bacteriology, 8th Ed. RE Buchaman and N.
E. Gibbons (Williams and Wilkins Co., 1974))
According to the description in It is strictly aerobic, and is non-fermentable in the OF test. Due to its various properties such as negative VP reaction, arginine decomposition ability, and negative phosphatase activity, it is most appropriate to assign it to the genus Arthrobacter. Next, the basic method for obtaining sulfated polysaccharide DF-4639 will be described. That is, DF−4639
All that is required is for DF-4639 to accumulate in the culture medium and the bacterial cells of the bacteria used to obtain the bacteria.For this purpose, any medium in which the bacteria used can grow can be used; In addition to carbon sources and nitrogen sources that can be converted into carbon, inorganic salts and vitamins can be used alone or in combination in appropriate proportions. Carbon sources include glucose and glycerin; nitrogen sources include yeast extract, meat extract, peptone, soybean flour,
Inorganic ammonium salts such as corn staple liquor, ammonium hydrogen phosphate, and ammonium nitrate are used, and in addition, appropriate amounts of metal salts such as magnesium, potassium, iron, and manganese can be added as inorganic salts. Furthermore, since DF-4639 is a sulfated polysaccharide, it is extremely meaningful to add an appropriate amount of sulfate such as sodium sulfate or ammonium sulfate. The culture temperature and pH of the medium can be within the range where the bacteria used can grow, but the temperature should be 25
It is preferable to culture at ~37°C and pH between 6.5 and 8.5. Cultivation is preferably carried out under aerobic conditions, for example by shaking culture or aerated agitation culture in a culture tank. The culture time may be 24 hours or more, but preferably 50 to 200 hours. When the culture is completed, the culture is separated into bacterial cells and a filtrate using a centrifuge, and the filtrate is treated as described below. Regarding bacterial cells,
If the amount is small, it can be ignored, but if it is large, it will be processed separately according to the method described later. That is, a solution of a quaternary ammonium salt, such as cetylpyridinium chloride (CPC), is added to the filtrate and stirred, and the resulting precipitate is separated and collected using a high-speed centrifuge. An electrolyte solution of an appropriate concentration, for example, 3 molar saline containing 10% ethanol, is added to the obtained precipitate and dissolved with stirring. Ethanol is added until no new precipitate is formed, and the resulting precipitate is collected, washed with ethanol and acetone, and dried to obtain a coarse powder. The coarse powder obtained here was dissolved in water again, and diluted hydrochloric acid was added to bring the pH to approx.
After adjusting to 1.0, centrifuge at low temperature (approximately 5°C) to remove insoluble matter. The supernatant is collected, neutralized with dilute caustic soda solution, and treated with a quaternary ammonium salt, such as cetyltrimethylammonium bromide (CTAB).
The precipitate formed by adding the aqueous solution is collected by centrifugation. The obtained precipitate is added to 1 molar saline solution, and impurities such as nucleic acids are sufficiently stirred and solubilized, followed by centrifugation to collect insoluble matter. This insoluble matter is added to 3 molar saline containing 10% ethanol and dissolved while heating to about 50°C. Ethanol is added to this solution to precipitate it, and the resulting precipitate is collected and washed with ethanol and then acetone, then dissolved again in water with stirring at room temperature and centrifuged at about 5°C to remove traces of insoluble matter. . Ethanol was added to the solution until no new precipitate was formed, and the resulting precipitate was collected and washed sequentially with ethanol, acetone, and ether.
Drying under reduced pressure at °C yields DF-4639 as a white powder. On the other hand, to obtain DF-4639 from bacterial cells, toluene or the like is added to an aqueous suspension of bacterial cells, and the suspension is left at room temperature to allow the bacterial cells to self-lyse, and the internal components of the bacterial cells are transferred to water. Ethanol is added to this suspension until the concentration reaches 40%, precipitated proteins, nucleic acids, etc. are removed by filtration along with bacterial cell residue, and the filtrate is concentrated to remove ethanol. Add CPC solution to this and collect the resulting precipitate.
The following treatment is performed in the same manner as for the culture filtrate. According to the above method, DF-4639 is obtained as a sodium salt of a sulfated polysaccharide, and has the following physicochemical properties. (a) Elemental analysis values, sugar and protein content Table 1 shows the values of 5 lots and the average value.

【表】 (b) グルコース、ガラクトース、硫酸基および燐
含量モル比 DF−4639を1規定硫酸中、100℃5時間加水
分解した後炭酸バリウムで中和し、Dowex
50W(H型)にかけて得られる流出液を用いて、
Khimらの方法(J.Am.Chem.Soc.、74、2090
(1952)を適用してグルコースとガラクトース
を分離定量した。また、硫酸基および燐のモル
比はSおよびPの含量(%)から算出した。第
2表にグルコースを1.0モルとした場合の各成
分のモル比の一例を示した。
[Table] (b) Molar ratio of glucose, galactose, sulfate groups, and phosphorus content DF-4639 was hydrolyzed in 1N sulfuric acid at 100°C for 5 hours, then neutralized with barium carbonate, and Dowex
Using the effluent obtained by applying 50W (H type),
The method of Khim et al. (J.Am.Chem.Soc., 74 , 2090
(1952) was applied to separate and quantify glucose and galactose. Furthermore, the molar ratio of sulfate groups and phosphorus was calculated from the S and P contents (%). Table 2 shows an example of the molar ratio of each component when glucose is 1.0 mol.

【表】 (c) アミノ酸およびアミノ糖の含量モル比 DF−4639を3規定塩酸中、100℃16時間加水
分解し、塩酸を留去してアミノ酸分析計にかけ
て定量した結果の一例をグルタミン酸を1.0モ
ルとして第3表に示した。
[Table] (c) Content molar ratio of amino acids and amino sugars An example of the results of hydrolyzing DF-4639 in 3N hydrochloric acid at 100℃ for 16 hours, distilling off the hydrochloric acid, and quantifying it using an amino acid analyzer is 1.0% of glutamic acid. It is shown in Table 3 as moles.

【表】 (d) 旋光度 [α]25 D−36±1°(C=1.0、水) (e) 分子量 23000(デキストランを標準物質とするゲル濾
過法における主ピーク) (f) 紫外部吸収 2mg/ml水溶液において220〜340nmに極大
吸収は認められない。 (g) 赤外線吸収スペクトル(KBr錠) 図1に示す通り、1240、840(肩)および810
cm-1に硫酸化多糖特有の吸収を示す。 DF−4639の生物学的諸性質を次に示す。 (a) 試験管内生物活性
[Table] (d) Optical rotation [α] 25 D −36±1° (C = 1.0, water) (e) Molecular weight 23000 (main peak in gel filtration method using dextran as a standard substance) (f) Ultraviolet absorption In a 2 mg/ml aqueous solution, no maximum absorption is observed between 220 and 340 nm. (g) Infrared absorption spectrum (KBr tablet) As shown in Figure 1, 1240, 840 (shoulder) and 810
It shows an absorption characteristic of sulfated polysaccharide in cm -1 . The biological properties of DF-4639 are shown below. (a) In vitro biological activity

【表】 (b) ラツトにおける線溶誘導活性 ラツトを用い、検体投与(静注)前後のユー
グロブリン溶解時間(ELT)を経時的に測定
し、次式により線溶活性増加率(%)として表
現した。
[Table] (b) Fibrinolysis induction activity in rats Using rats, the euglobulin lysis time (ELT) was measured over time before and after administration of the sample (intravenous injection), and was calculated as the fibrinolytic activity increase rate (%) using the following formula. expressed.

【表】 (c) 急性毒性 LD501500mg/Kg以上(マウス、静注) 以上のごとく、DF−4639は試験管内およびラ
ツトを用いた実験において、ヘパリンと同等もし
くはそれ以上の線溶誘導活性を示すことが確認さ
れた。しかもDF−4639においては、好ましくな
い抗凝固活性がヘパリンに比し著しく弱いという
特徴を有している。さらには赤血球凝集促進作用
も認められず、急性毒性値も1500mg/Kg以上(静
注)であり、副作用が非常に少なく、抗血栓薬と
して有望である。また、本発明者らは、DF−
4639にはリポプロテインリパーゼ活性化作用、抗
癌作用および感染防御作用などの有用な作用のあ
ることを動物実験で知見している。 次に製造実施例を挙げて説明するが、%は特に
記載があるものを除きw/v%である。 実施例 1 グルコース2%、ペプトン0.5%、コーンステ
イープリカー0.5%、酵母エキス0.3%、食塩0.5%
および炭酸カルシウム0.3%よりなる液体培地100
mlを含む500mlの振盪フラスコに予め寒天斜面培
地に成育したAT−25菌の1白金耳を接種し、30
℃において3日間振盪培養して種培養液を得た。
次にグリセリン2%、硫安0.5%、燐酸−カリウ
ム0.1%、硫酸ナトリウム0.05%、酵母エキス0.2
%よりなる培地20を30容のジヤーフアーメン
ターに加え120℃で20分間滅菌したのち、PHを7.5
に調整する。これに種培養液600mlを接種して温
度30℃、通気量毎分10、撹拌毎分250回転の条
件で159時間培養した。得られた培養液を遠心分
離して少量の菌体を除去し、上澄液18に10%セ
チルピリジニウムクロライド水溶液500mlを加え、
一昼夜放置後、沈澱を遠心分離した。これを3M
食塩−10%(v/v)エタノール溶液600mlに加
え、充分に撹拌して溶解させた後、エタノール
1.6を加えて生じた沈澱をグラスフイルターを
用いて濾別した。この沈澱をエタノール、次いで
アセトンで洗い、乾燥して粗粉末37.0gを得た。
これを500mlの水に溶解し、0℃において1N塩酸
で約PH1.0として生ずる沈澱を遠心分解して除き、
上清を中和後、10%セチルトリメチルアンモニウ
ムブロマイド水溶液500mlを加え、生じた沈澱を
遠心分離した。沈澱を1M食塩水で充分洗つた後、
3M食塩−10%(v/v)エタノール溶液150mlを
加え、充分に撹拌して溶解せしめ、エタノール
450mlを加えて一夜放置後、遠心分離して沈澱物
を集めた。これをエタノールで洗浄後、再び水
150mlに溶解せしめ、グラスフイルターで濾過し、
少量の残渣を水50mlで洗浄した。濾液および洗液
を合し、撹拌しながらエタノール2中に注ぎ、
白色沈澱を生成せしめた。この沈澱をグラスフイ
ルターで濾別し、エタノール、アセトン及びエー
テルで順次洗浄し、55℃で5時間減圧乾燥し、白
色粉末のDF−4639を13.9g得た。本物質は、前
記の物性を示すものであり、トロンビン活性の50
%阻害濃度は0.7μg/mlであつた。 実施例 2 グリセリン2%、可溶性でん粉1%、肉エキス
1%、ペプトン1%および食塩0.2%よりなる培
地20を30容のジヤーフアーメンターに加え
て、120℃、20分間滅菌し、実施例1と同様にし
て65時間培養を行つた。培養終了後、培養液を遠
心分離して、菌体と上清に分けた。上清に10%セ
チルピリジニウムクロライド水溶液150mlを加え、
以下実施例1に従つて分離精製して、DF−4639
の白色粉末3.2gを得た。一方、菌体は1200mlの
水と300mlのトルエン混合液中に懸濁し、時々撹
拌しながら、室温下3日間放置した。トルエンを
減圧留去後、エタノールを約40%(v/v)にな
る迄加え、沈殿して来る蛋白および核酸などを菌
体と共に濾過して除いた。得られた濾液を約1
迄に減圧下濃縮後、10%食塩水30mlおよび10%セ
チルピリジニウムクロライド水溶液100mlを加え
て生じた沈殿を遠心分離した。以下、実施例1に
従つて分離精製し、白色粉末のDF−4639を2.4g
得た。
[Table] (c) Acute toxicity LD 50 1500 mg/Kg or more (mouse, intravenous injection) As described above, DF-4639 has fibrinolytic inducing activity equivalent to or greater than heparin in in vitro and rat experiments. It was confirmed that Moreover, DF-4639 has a characteristic that its undesirable anticoagulant activity is significantly weaker than that of heparin. Furthermore, no hemagglutinating effect was observed, and the acute toxicity value was over 1500 mg/Kg (intravenous injection), so it has very few side effects and is promising as an antithrombotic drug. In addition, the present inventors have discovered that DF-
Animal experiments have shown that 4639 has useful effects such as lipoprotein lipase activation, anticancer, and infection prevention effects. Next, manufacturing examples will be described, in which % is w/v % unless otherwise specified. Example 1 Glucose 2%, peptone 0.5%, cornstarch liquor 0.5%, yeast extract 0.3%, salt 0.5%
Liquid medium 100 consisting of and 0.3% calcium carbonate
One platinum loop of AT-25 bacteria grown on an agar slant was inoculated into a 500 ml shake flask containing 30 ml of
A seed culture solution was obtained by culturing with shaking at ℃ for 3 days.
Next, 2% glycerin, 0.5% ammonium sulfate, 0.1% potassium phosphate, 0.05% sodium sulfate, and 0.2 yeast extract.
After adding 20% medium to 30 volumes of jar fermenter and sterilizing it at 120℃ for 20 minutes, the pH was adjusted to 7.5.
Adjust to. This was inoculated with 600 ml of seed culture solution and cultured for 159 hours at a temperature of 30°C, an aeration rate of 10 per minute, and a stirring rate of 250 revolutions per minute. The obtained culture solution was centrifuged to remove a small amount of bacterial cells, and 500 ml of 10% cetylpyridinium chloride aqueous solution was added to the supernatant liquid 18.
After standing overnight, the precipitate was centrifuged. This is 3M
Add to 600 ml of common salt-10% (v/v) ethanol solution, stir thoroughly to dissolve, and then add ethanol.
A precipitate formed by adding 1.6 was filtered out using a glass filter. This precipitate was washed with ethanol, then with acetone, and dried to obtain 37.0 g of crude powder.
Dissolve this in 500ml of water, adjust the pH to approximately 1.0 with 1N hydrochloric acid at 0°C, remove the resulting precipitate by centrifugation,
After neutralizing the supernatant, 500 ml of 10% aqueous cetyltrimethylammonium bromide solution was added, and the resulting precipitate was centrifuged. After thoroughly washing the precipitate with 1M saline,
Add 150ml of 3M salt-10% (v/v) ethanol solution, stir thoroughly to dissolve, and add ethanol.
After adding 450 ml and leaving it overnight, the precipitate was collected by centrifugation. After washing it with ethanol, water it again.
Dissolve in 150ml, filter through a glass filter,
A small amount of residue was washed with 50 ml of water. Combine the filtrate and washing liquid and pour into ethanol 2 with stirring,
A white precipitate was formed. This precipitate was filtered through a glass filter, washed successively with ethanol, acetone, and ether, and dried under reduced pressure at 55°C for 5 hours to obtain 13.9 g of DF-4639 as a white powder. This substance exhibits the above-mentioned physical properties and has a 50% reduction in thrombin activity.
The % inhibitory concentration was 0.7 μg/ml. Example 2 Medium 20 consisting of 2% glycerin, 1% soluble starch, 1% meat extract, 1% peptone and 0.2% salt was added to a 30 volume jar fermenter and sterilized at 120°C for 20 minutes. Culture was carried out for 65 hours in the same manner as in 1. After the culture was completed, the culture solution was centrifuged and separated into bacterial cells and supernatant. Add 150ml of 10% cetylpyridinium chloride aqueous solution to the supernatant,
Following separation and purification according to Example 1, DF-4639
3.2 g of white powder was obtained. On the other hand, the bacterial cells were suspended in a mixture of 1200 ml of water and 300 ml of toluene, and left at room temperature for 3 days with occasional stirring. After toluene was distilled off under reduced pressure, ethanol was added to the solution to a concentration of about 40% (v/v), and precipitated proteins and nucleic acids were removed by filtration along with the bacterial cells. The obtained filtrate is about 1
After concentration under reduced pressure, 30 ml of 10% saline and 100 ml of 10% aqueous cetylpyridinium chloride solution were added, and the resulting precipitate was centrifuged. Hereinafter, 2.4 g of white powder DF-4639 was isolated and purified according to Example 1.
Obtained.

【図面の簡単な説明】[Brief explanation of drawings]

図1は赤外線吸収スペクトルである。 Figure 1 is an infrared absorption spectrum.

Claims (1)

【特許請求の範囲】[Claims] 1 硫酸化多糖体DF−4639生産能を有するアル
スロバクター属 sp.AT−25。
1. Arthrobacter sp.AT-25 capable of producing sulfated polysaccharide DF-4639.
JP8371088A 1988-04-05 1988-04-05 Microbial strain at-25 Granted JPS63273471A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8371088A JPS63273471A (en) 1988-04-05 1988-04-05 Microbial strain at-25

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8371088A JPS63273471A (en) 1988-04-05 1988-04-05 Microbial strain at-25

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP14489579A Division JPS5667301A (en) 1979-11-08 1979-11-08 Sulfated polysaccharide

Publications (2)

Publication Number Publication Date
JPS63273471A JPS63273471A (en) 1988-11-10
JPH027631B2 true JPH027631B2 (en) 1990-02-20

Family

ID=13810055

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8371088A Granted JPS63273471A (en) 1988-04-05 1988-04-05 Microbial strain at-25

Country Status (1)

Country Link
JP (1) JPS63273471A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107988105B (en) * 2017-12-15 2021-06-18 中国科学院海洋研究所 Marine bacillus and application thereof
CN115895930B (en) * 2021-08-31 2023-10-31 微元合成生物技术(北京)有限公司 Salt-tolerant bacillus and application of levan produced by same

Also Published As

Publication number Publication date
JPS63273471A (en) 1988-11-10

Similar Documents

Publication Publication Date Title
KR870001815B1 (en) Process for preparing hyaluronic acid by method of fermentation
JP2571908B2 (en) Streptococcus used for production of high molecular weight sodium hyaluronate and method for selecting the same
JPH068322B2 (en) Pectin manufacturing method
JP3865801B2 (en) Novel β-agarase, process for producing the same and use thereof
JP2726274B2 (en) Novel keratan sulfate degrading enzyme and microorganism and method for producing the same
JPH027631B2 (en)
JP3525190B2 (en) Strain producing ε-poly-L-lysine in remarkable quantity and method for producing ε-poly-L-lysine using the same
JP2894293B2 (en) Galactanase S-39 and Bacillus sp. S-39 producing the same
JPH0144721B2 (en)
JPS6344128B2 (en)
KR100312638B1 (en) Method for manufacturing high purity hyaluronic acid
JPH0443637B2 (en)
JPH0342075B2 (en)
JPS61219394A (en) Production of hyaluronic acid through fermentation
JPH0342070B2 (en)
JPS62257382A (en) Novel streptococcus zooepidemicus
JPH0568537A (en) Microbial strain of producing epsilon-poly-l-lysine
JPH046356B2 (en)
JPH0378998B2 (en)
JP3026312B2 (en) Production method of chitin degradation products
JP2901458B2 (en) Method for producing gentianose
JP2833081B2 (en) Method for producing inulotriose and / or inulotetraose
JPH0630603B2 (en) Hyaluronic acid manufacturing method
JPH08280396A (en) Production of trehalose
JPH0124121B2 (en)